Stoke Therapeutics

3 Preston Court
Suite 102
Bedford
Massachusetts
01730
United States

Tel: 781-430-8200

Email: info@stoketherapeutics.com

Show jobs for this employer

About Stoke Therapeutics

Stoke Therapeutics is a biotechnology company working to increase gene expression to treat a wide array of severe genetic diseases, including genetic conditions affecting the central nervous system, eye, and liver. Stoke was launched in 2018 with a $40 million Series A investment funded by Apple Tree Partners.

YEAR FOUNDED:
2018

LEADERSHIP:
Founder, CBO and COO: Huw M. Nash, Ph.D.
CEO: Edward M. Kaye, M.D.
CMO: Barry Ticho, M.D., Ph.D., FACC
Co-Founder & VP, Head of Biology: Isabel Aznarez, Ph.D
VP, Head of Chemistry: Charles R. Allerson, Ph.D.

PIPELINE:
Please click here for Stoke Therapeutics' pipeline

CAREER:
Please click here for Stoke Therapeutics' job opportunities.

26 articles with Stoke Therapeutics